v3.26.1
CASH AND CASH EQUIVALENTS, FUNDS RECEIVABLE AND CUSTOMER ACCOUNTS, AND INVESTMENTS
3 Months Ended
Mar. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
CASH AND CASH EQUIVALENTS, FUNDS RECEIVABLE AND CUSTOMER ACCOUNTS, AND INVESTMENTS CASH AND CASH EQUIVALENTS, FUNDS RECEIVABLE AND CUSTOMER ACCOUNTS, AND INVESTMENTS
The following table summarizes the assets underlying our cash and cash equivalents, funds receivable and customer accounts, short-term investments, and long-term investments as of March 31, 2026 and December 31, 2025:
 March 31,
2026
December 31,
2025
(In millions)
Cash and cash equivalents(1)
$6,977 $8,049 
Funds receivable and customer accounts:
Cash and cash equivalents(2)
$15,466 $15,969 
Time deposits77 94 
Available-for-sale debt securities15,827 14,457 
Funds receivable8,131 7,678 
Total funds receivable and customer accounts$39,501 $38,198 
Short-term investments:
Time deposits$79 $88 
Available-for-sale debt securities2,286 2,285 
Total short-term investments$2,365 $2,373 
Long-term investments:
Time deposits$$
Available-for-sale debt securities2,313 2,421 
Strategic investments1,806 1,904 
Total long-term investments$4,125 $4,330 
(1) Includes $250 million and nil of available-for-sale debt securities with original maturities of three months or less as of March 31, 2026 and December 31, 2025, respectively.
(2) Includes $187 million and $374 million of available-for-sale debt securities with original maturities of three months or less as of March 31, 2026 and December 31, 2025, respectively.
As of March 31, 2026 and December 31, 2025, the estimated fair value of our available-for-sale debt securities included within cash and cash equivalents, funds receivable and customer accounts, short-term investments, and long-term investments was as follows:
 
March 31, 2026(1)
 Gross
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(In millions)
Cash and cash equivalents:
U.S. government and agency securities$250 $— $— $250 
Funds receivable and customer accounts:
U.S. government and agency securities4,173 — 4,174 
Foreign government and agency securities85 — — 85 
Corporate debt securities2,411 (1)2,412 
Mortgage-backed and asset-backed securities4,232 (4)4,237 
Municipal securities33 — — 33 
Commercial paper4,475 (1)4,475 
Short-term investments:
U.S. government and agency securities395 — — 395 
Foreign government and agency securities110 — — 110 
Corporate debt securities809 — (1)808 
Mortgage-backed and asset-backed securities404 — (1)403 
Commercial paper570 — — 570 
Long-term investments:
U.S. government and agency securities480 — — 480 
Corporate debt securities542 — 543 
Mortgage-backed and asset-backed securities1,288 (1)1,290 
Total available-for-sale debt securities(2)
$20,257 $17 $(9)$20,265 
(1) “—” Denotes gross unrealized gain or unrealized loss of less than $1 million in a given position.
(2) Excludes foreign currency denominated available-for-sale debt securities accounted for under the fair value option. Refer to “Note 9Fair Value Measurement of Assets and Liabilities.”
 
December 31, 2025(1)
 Gross
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(In millions)
Funds receivable and customer accounts:
U.S. government and agency securities$3,529 $$— $3,530 
Foreign government and agency securities81 — — 81 
Corporate debt securities2,438 (1)2,441 
Mortgage-backed and asset-backed securities
3,825 (1)3,831 
Municipal securities98 — — 98 
Commercial paper4,229 — 4,230 
Short-term investments:
U.S. government and agency securities443 — — 443 
Foreign government and agency securities60 — — 60 
Corporate debt securities985 (2)984 
Mortgage-backed and asset-backed securities
448 — — 448 
Commercial paper350 — — 350 
Long-term investments:
U.S. government and agency securities400 — — 400 
Foreign government and agency securities50 — — 50 
Corporate debt securities648 — 650 
Mortgage-backed and asset-backed securities
1,320 (1)1,321 
Total available-for-sale debt securities(2)
$18,904 $18 $(5)$18,917 
(1) “—” Denotes gross unrealized gain or unrealized loss of less than $1 million in a given position.
(2) Excludes foreign currency denominated available-for-sale debt securities accounted for under the fair value option. Refer to “Note 9Fair Value Measurement of Assets and Liabilities.”

Gross amortized cost and estimated fair value balances exclude accrued interest receivable on available-for-sale debt securities, which totaled $97 million and $101 million at March 31, 2026 and December 31, 2025, respectively, and were included in other current assets on our condensed consolidated balance sheets.
As of March 31, 2026 and December 31, 2025, the gross unrealized losses and estimated fair value of our available-for-sale debt securities included within cash and cash equivalents, funds receivable and customer accounts, short-term investments, and long-term investments for which an allowance for credit losses was not deemed necessary in the current period, aggregated by the length of time those individual securities have been in a continuous loss position, was as follows:
 
March 31, 2026(1)
Less than 12 months12 months or longerTotal
 Fair ValueGross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
(In millions)
Cash and cash equivalents:
U.S. government and agency securities$250 $— $— $— $250 $— 
Funds receivable and customer accounts:
U.S. government and agency securities2,159 — 15 — 2,174 — 
Foreign government and agency securities49 — — — 49 — 
Corporate debt securities1,000 (1)— — 1,000 (1)
Mortgage-backed and asset-backed securities1,661 (4)57 — 1,718 (4)
Commercial paper1,999 (1)— — 1,999 (1)
Short-term investments:
U.S. government and agency securities295 — — — 295 — 
Foreign government and agency securities25 — 20 — 45 — 
Corporate debt securities233 — 94 (1)327 (1)
Mortgage-backed and asset-backed securities247 (1)53 — 300 (1)
Commercial paper470 — — — 470 — 
Long-term investments:
U.S. government and agency securities210 — — — 210 — 
Corporate debt securities235 — — — 235 — 
Mortgage-backed and asset-backed securities389 (1)— 395 (1)
Total available-for-sale debt securities$9,222 $(8)$245 $(1)$9,467 $(9)
(1) “—” Denotes gross unrealized loss or fair value of less than $1 million in a given position.
 
December 31, 2025(1)
Less than 12 months12 months or longerTotal
 Fair ValueGross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
(In millions)
Funds receivable and customer accounts:
U.S. government and agency securities$1,261 $— $50 $— $1,311 $— 
Foreign government and agency securities56 — — — 56 — 
Corporate debt securities309 (1)— — 309 (1)
Mortgage-backed and asset-backed securities
1,000 (1)206 — 1,206 (1)
Commercial paper1,375 — — — 1,375 — 
Short-term investments:
U.S. government and agency securities443 — — — 443 — 
Foreign government and agency securities— — 20 — 20 — 
Corporate debt securities94 (1)109 (1)203 (2)
Mortgage-backed and asset-backed securities
354 — — 360 — 
Commercial paper200 — — — 200 — 
Long-term investments:
Foreign government and agency securities25 — — — 25 — 
Corporate debt securities20 — — — 20 — 
Mortgage-backed and asset-backed securities
368 (1)35 — 403 (1)
Total available-for-sale debt securities$5,505 $(4)$426 $(1)$5,931 $(5)
(1) “—” Denotes gross unrealized loss or fair value of less than $1 million in a given position.

Unrealized losses have not been recognized into income as we neither intend to sell, nor anticipate that it is more likely than not that we will be required to sell, the securities before recovery of their amortized cost basis. The decline in fair value was due primarily to changes in market interest rates, rather than credit losses. We will continue to monitor the performance of the investment portfolio and assess whether impairment due to expected credit losses has occurred.

The table below presents cash inflows related to available-for-sale debt securities:
 Three Months Ended March 31,
20262025
(In millions)
Proceeds from sales and maturities of available-for-sale debt securities
$5,279 $5,472 

During the three months ended March 31, 2026 and 2025, we incurred gross realized gains and losses which were de minimis. Gross realized gains and losses were determined using the specific identification method.

Our available-for-sale debt securities included within cash and cash equivalents, funds receivable and customer accounts, short-term investments, and long-term investments classified by date of contractual maturity were as follows:
 March 31, 2026
Amortized CostFair Value
(In millions)
One year or less $10,214 $10,213 
After one year through five years4,579 4,582 
After five years through ten years2,391 2,387 
After ten years3,073 3,083 
Total$20,257 $20,265 

Actual maturities may differ from contractual maturities as certain securities may be prepaid.
STRATEGIC INVESTMENTS

Our strategic investments include marketable equity securities, which are publicly traded, and non-marketable equity securities, which are primarily investments in privately held companies. Our marketable equity securities have readily determinable fair values and are recorded as long-term investments on our condensed consolidated balance sheets at fair value with changes in fair value recorded in other income (expense), net on our condensed consolidated statements of income (loss). Marketable equity securities totaled $106 million and $180 million as of March 31, 2026 and December 31, 2025, respectively. As of March 31, 2026, we held marketable equity securities with a fair value of $94 million with a time-based contractual sale restriction, which is set to expire in May 2026.

Our non-marketable equity securities are recorded as long-term investments on our condensed consolidated balance sheets. The carrying value of our non-marketable equity securities totaled $1.7 billion as of both March 31, 2026 and December 31, 2025. As of both March 31, 2026 and December 31, 2025, we had non-marketable equity securities of $215 million for which we have the ability to exercise significant influence, but not control, over the investee. We account for these equity securities using the equity method of accounting. The remaining non-marketable equity securities do not have a readily determinable fair value and we measure these equity investments at cost minus impairment, if any, and adjust for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer (the “Measurement Alternative”). All gains and losses on these investments, realized and unrealized, and our share of earnings or losses from investments accounted for using the equity method are recognized in other income (expense), net on our condensed consolidated statements of income (loss).

Measurement Alternative adjustments

The adjustments to the carrying value of our non-marketable equity securities accounted for under the Measurement Alternative in the three months ended March 31, 2026 and 2025 were as follows:
Three Months Ended March 31,
 20262025
(In millions)
Carrying amount, beginning of period$1,509 $1,336 
Adjustments related to non-marketable equity securities:
Net additions (reductions)(1)
(1)22 
Gross unrealized gains45 55 
Gross unrealized losses and impairments(68)— 
Carrying amount, end of period$1,485 $1,413 
(1) Net additions (reductions) include purchases, reductions due to sales of securities, and reclassifications when the Measurement Alternative is subsequently elected or no longer applies.

The following table summarizes the cumulative gross unrealized gains and cumulative gross unrealized losses and impairment related to non-marketable equity securities accounted for under the Measurement Alternative held at March 31, 2026 and December 31, 2025, respectively:
March 31,
2026
December 31,
2025
(In millions)
Cumulative gross unrealized gains $917 $872 
Cumulative gross unrealized losses and impairments$(421)$(353)
Unrealized gains (losses) on strategic investments, excluding those accounted for using the equity method

The following table summarizes the net unrealized gains (losses) on marketable and non-marketable equity securities, excluding those accounted for using the equity method, held at March 31, 2026 and 2025, respectively:
 Three Months Ended March 31,
 20262025
(In millions)
Net unrealized gains (losses)$(97)$48 

Supplemental cash flow information related to investments
Non-cash investing transactions that were not reflected in the condensed consolidated statement of cash flows for the three months ended March 31, 2026 and 2025 include the purchase of investments of $25 million and $125 million, respectively, that have not yet settled.